prnewswire.comOct 28$PRPL

Purple Innovation to Report Third Quarter 2026 Results on November 4, 2026

Purple Innovation (PRPL) will release Q3 2026 earnings on Nov. 4, 2026, and host a conference call at 4:30 p.m. ET. The call will be available via webcast and replay. The company specializes in mattresses and sleep products.

Original reporting

prnewswire.com

Published Oct 28, 2026, 8:15 PM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Oct 28, 2026, 8:20 PM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

Source · prnewswire.com

Decision brief

The 30-second read

$PRPLNeutralMed

Why it matters

The announcement sets the calendar for investors to prepare for the Q3 2026 earnings, which may influence short‑term trading activity.

Market read

Earnings date announcements are standard corporate news but provide a concrete timing cue for traders.

What to watch

Potential supply‑chain constraints or raw‑material cost changes could affect results.

Relevance 5/10Novelty 5/10Timing: Nov 4, 2026 earnings release

Background

Purple Innovation is a mattress and sleep‑product company that regularly reports quarterly results.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$PRPLNeutralHigh confidence

Context

Purple Innovation announced it will report its Q3 2026 earnings on November 4, 2026.

Expected impact

potential short‑term price swing around the earnings call

Evidence & confidence

Earnings dates are material events; traders often adjust positions before the report.

Market effects

Sector

Provides a timing cue for the consumer sleep‑goods sector and related retail stocks.

Regional

Limited to U.S. investors; no broader regional effect.

Global

Low, as the company is a niche player.

Counterpoint

What could challenge this read

If the market has already priced in strong growth, the earnings could disappoint.

Key entities

Company
Purple Innovation, Inc.
Comfort innovation company (NASDAQ: PRPL) reporting Q3 2026 results.

Read at source ← All news

$PRPLMed

Purple Innovation Reports Third Quarter 2026 Results

Purple Innovation, Inc. (PRPL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 CONFIDENTIAL DRAFT Purple Innovation Reports Third Quarter 2026 Results Positive Operating Cash Flow for the Third Consecutive Quarter Preparing for Major Mattress Portfolio Refresh to Strengthen Performance in 2027 Lehi, Utah, November 4, 2026 – Purple Innovation, I

SEC EDGAR 8-KNov 4

$PRPLMedAI 8/10

Why Purple (PRPL) Stock Is Trading Lower Today

Purple (PRPL) shares fell 24.6% after the company reported Q2 revenue of $98.27 million, down 6.5% year over year and below Wall Street expectations. Adjusted EPS was a loss of $1.52, better than forecast. Purple kept full-year revenue guidance around $430 million, but investors focused on the quarterly sales miss.

financialcontent.comAug 11

$PRPLMed

Purple Innovation Reports Second Quarter 2026 Results

Purple Innovation, Inc. (PRPL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Purple Innovation Reports Second Quarter 2026 Results Showroom Revenue Up 16.6% and Comparable Revenue Up 18% GAAP Net Loss of $3.2 Million in the Second Quarter Adjusted EBITDA Improves $4.4 Million to $2.1 Million Regains Compliance with Nasdaq Minimum Bid Price Re

SEC EDGAR 8-KAug 10

$PRPLMedAI 8/10

Purple (NASDAQ:PRPL) Misses Q2 CY2026 Sales Expectations

Purple (NASDAQ:PRPL) reported Q2 CY2026 revenue of $98.27 million, down 6.5% year on year, missing market expectations. Non-GAAP adjusted EPS was -$1.52, better than analysts’ consensus. For next quarter, management guided revenue to $430 million at the midpoint. The article also notes negative operating margin and ongoing revenue decline.

financialcontent.comAug 10

Med

TELUS (TU) Q3 2026 Earnings Call Transcript

TELUS (TU) outlined three key priorities during its Q3 2026 earnings call: strengthening its financial foundation, honing operational discipline, and deploying resources for growth. The company aims to reduce debt, achieve a net debt to adjusted EBITDA leverage ratio of 3x or lower by 2028, and target $900 million in annualized cash savings by 2028. TELUS plans to monetize non-core assets, streamline operations, and invest in its PureFibre network for growth in AI infrastructure.

finance.yahoo.comNov 7

$PAHCMedAI 8/10

Phibro Animal (PAHC) Q1 2027 Earnings Call Transcript

Phibro Animal Health (PAHC) reported Q1 2027 sales growth of 6% to $386.8M and adjusted EBITDA growth of 4% to $64.3M. Performance Products and Mineral Nutrition segments drove growth, while Animal Health saw a 3% increase. The company maintained its full-year guidance and expects protein demand to grow, despite near-term pressure on producer profitability.